Hinge Health, Inc.

NYSE:HNGE

Medical - Healthcare Information Services

Healthcare
$114.53 -0.36%

-$0.24 today

Market cap
$9.31B
Beta
1.99
P/E (TTM)
-10.3
EPS (TTM)
-$6.49
52W Low $30.08High $70.72

Volume 1.23M

Average 1.34M

HNGE Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Hinge Health, Inc.NYSE: HNGE

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 86.4%

Gross margin was 86.4% in Q2 FY2026, up 16.2 pp from a year earlier. On a trailing-twelve-month basis it was 84.5%, up 6.9 pp year over year.

Context

  • Gross margin widened in 2 of the last 2 fiscal years.
  • FY2025 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
86.4%+1.8 pp QoQ
Last fiscal yearDec 2025
79.8%+2.8 pp YoY
LTMJun 2026
84.5%+6.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+16.2 pp——
1 year+2.8 pp——
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
79.8%
Year-over-year change
+2.8pp

Gross Margin vs competitors

How HNGE compares with its peers on the latest reported figures

  • HNGE's LTM Jun 2026 gross margin of 84.5% is the highest of the 5 companies compared; the peer median is 61.5%.
  • Its year-over-year change of +6.9 pp is the highest of 5, against a peer median of +0.8 pp.
HNGE Competitors Peer median
Gross Margin for HNGE and competitors
Company Period LTM level YoY 3-year change
HNGEHinge Health, Inc.LTM Jun 202684.5% +6.9 pp—
SNNSmith & Nephew plcFY202568.3% -2.0 pp-2.7 pp
OMDAOmada HealthLTM Mar 202666.2% +4.6 pp+17.7 pp
ENOVEnovis CorporationLTM Apr 202656.8% +0.3 pp+4.2 pp
USPHU.S. Physical Therapy, Inc.LTM Mar 202620.4% +1.3 pp-0.1 pp
Peer median (excluding HNGE) 61.5%+0.8 pp+2.1 pp

Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue292.73M390.4M587.86M
Cost of Revenue98.55M89.81M118.56M
Gross Profit194.18M300.59M469.3M
Gross Margin66.3%77.0%79.8%
Research & Development110.06M100.84M368.14M
Selling, General & Admin214.64M227.54M639.41M
Operating Expenses324.69M332.5M1.02B
Depreciation & Amortization5.63M5.95M5.13M
EBITDA(124.89M)(18.48M)(535.89M)
EBITDA Margin-42.7%-4.7%-91.2%
Operating Income(130.51M)(31.91M)(546.37M)
Operating Margin-44.6%-8.2%-92.9%
Interest Income000
Interest Expense000
Other Income / Expenses21.97M20.65M19.11M
Income Before Tax(108.55M)(11.26M)(527.26M)
Pre-Tax Margin-37.1%-2.9%-89.7%
Income Tax Expense(405K)677K998K
Net Income(108.14M)(11.93M)(528.26M)
Net Margin-36.9%-3.1%-89.9%
EPS (Basic)(1.39)(0.15)(5.36)
EPS (Diluted)(1.39)(0.15)(5.19)
Weighted Avg Shares78.02M78.02M79.19M
Weighted Avg Shares (Diluted)78.02M78.02M81.7M

Hinge Health, Inc.

NYSE:HNGE

Intrinsic Alpha fair value

Locked

Current Price

$114.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.